The resources and areas of expertise necessary to establish and maintain a successful children's cochlear implant program is discussed. Insights based on experience with a pediatric patient population are presented.
1Department of Otolaryngology, University of Michigan Medical Center, Ann Arbor, Michigan.
Presented to the FDA panel on the pre-market approval of the Cochlear Corporation multi-electrode cochlear implant for children, November 13, 1989.
Supported in part by NIH grant #P01 NS21440.
2Reprint requests: Paul R. Kileny, Ph.D., CCC-A, Department of Otolaryngology, University of Michigan Hospitals, TC-1904, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0312
In this era of double blinded, statistically valid research, there remains a place for empiric or even anecdotal observation. This section of the Journal creates a vehicle for the communication of such observation.
Content should be regarded as interesting or thought provoking or as a novel “discovery” that is not presented as valid science, statistically or otherwise. The opinions and observations are those of the author. Any recommendation as to standard of care or treatment guidelines is neither explicit nor implied.
It is our hope that this section will stimulate dialogue and an exchange of experience. The perspective of “observation” should not be displaced.